# Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine

> **NCT00877357** · PHASE4 · UNKNOWN · sponsor: **Shantha Biotechnics Limited** · enrollment: 3000 (estimated)

## Conditions studied

- Diphtheria
- Tetanus
- Pertussis
- Hepatitis B
- Haemophilus Influenzae Type B

## Interventions

- **BIOLOGICAL:** Shan 5

## Key facts

- **NCT ID:** NCT00877357
- **Lead sponsor:** Shantha Biotechnics Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-02
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2009-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00877357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00877357, "Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00877357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*